University of California-Irvine announced it will conduct clinical trials for stem cell treatment in partnership with University of California-Los Angeles under an $8 million grant.
UCI has a preclinical stem cell research program, and this moves it to the next step of testing, the school said.
“To advance treatments in this field, we all have to work together, and that’s what the UCI-UCLA … program represents,” said Sidney Golub, director of UCI’s Sue & Bill Gross Stem Cell Research Center.
Researchers from UCI’s center and UCLA’s Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research will oversee the work under the direction of Dr. John Adams of UCLA’s Broad Center.
The grant was one of three made today by the state’s California Institute of Regenerative Medicine.